Engineers Gate Manager LP Collegium Pharmaceutical, Inc Transaction History

Engineers Gate Manager LP

$5.55 Billion
Q1 2025

A detailed history of Engineers Gate Manager LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Engineers Gate Manager LP holds 26,372 shares of COLL stock, worth $921,173. This represents 0.01% of its overall portfolio holdings.

Number of Shares

26,372

Previous 33,732 21.82%

Holding current value

$921,173

Previous $966,000 18.53%

% of portfolio

0.01%

Previous 0.02%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$28.04 - $33.91 $206,374 - $249,577	-7,360 Reduced 21.82%	26,372 $787,000
Q4 2024 Feb 14, 2025	BUY	$28.61 - $41.86 $965,072 - $1.41 Million	33,732 New	33,732 $966,000
Q2 2024 Aug 14, 2024	SELL	$31.36 - $39.99 $177,811 - $226,743	-5,670 Reduced 37.59%	9,414 $303,000
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $83,103 - $108,861	2,661 Added 21.42%	15,084 $585,000
Q4 2023 Feb 14, 2024	BUY	$21.16 - $30.8 $54,656 - $79,556	2,583 Added 26.25%	12,423 $382,000
Q3 2023 Nov 14, 2023	BUY	$21.23 - $24.28 $208,903 - $238,915	9,840 New	9,840 $219,000
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $201,258 - $265,538	-12,754 Closed	0 $0
Q2 2020 Aug 17, 2020	SELL	$15.49 - $23.51 $233,434 - $354,295	-15,070 Reduced 54.16%	12,754 $223,000
Q1 2020 May 15, 2020	BUY	$13.89 - $25.45 $386,475 - $708,120	27,824 New	27,824 $454,000
Q2 2019 Aug 14, 2019	SELL	$10.62 - $16.59 $361,005 - $563,943	-33,993 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$13.58 - $18.72 $461,624 - $636,348	33,993 New	33,993 $515,000
Q2 2018 Aug 03, 2018	SELL	$21.79 - $28.29 $309,788 - $402,198	-14,217 Closed	0 $0
Q1 2018 May 07, 2018	BUY	$18.15 - $29.21 $258,038 - $415,278	14,217 New	14,217 $363,000

Others Institutions Holding COLL

# of Institutions

250

Shares Held

37.1M

Call Options Held

61.1K

Put Options Held

5.8K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.19B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Collegium Pharmaceutical, Inc Transaction History